AstraZeneca says advanced trial of breast-cancer drug Capivasertib meets primary endpoints
admin AstraZeneca PLC said Wednesday that Capivasertib plus Faslodex significantly improved progression-free survival when compared with…
Read MoreCancer Drugs
Celcuity stock soars after hours on breakthrough therapy designation for cancer drug
Shares of Celcuity Inc. CELC were up 17% at $10.80 after hours as the U.S.…
Read More